Prices are updated after-hours
  Health Technology United states

nasdaq:MMNFF MedMen Enterprises, Inc.

MMNFF 4 | $0.001 1440.0% 150K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-93.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-87.79% volume)
Earnings Calendar:
Market Cap: $ 500,344
http://www.medmen.com
 Sec Filling | Patents | n/a employees


(US) MedMen Enterprises, Inc. engages in the cultivation, production, and retailing of cannabis supply chain. It operates growing and manufacturing facilities which use agronomic technology and sustainable techniques. The company was founded by Adam Bierman and Andrew Modlin in 2010 and is headquartered in Culver City, CA.
cannabis  

add to watch list Paper trade email alert is off

nyse:VAPO Vapotherm, Inc.

VAPO | $1.27 -37.0% 13K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (147.1% 1y) (0.0% 2d) (6.7% 3d) (0.0% 7d) (-18.04% volume)
Earnings Calendar:
Market Cap: $ 7,795,683
http://www.vapotherm.com
 Sec Filling | Patents | 284 employees


(US) Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter. The company was founded by William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.
respiratory  

add to watch list Paper trade email alert is off

nasdaq:FSTX F-star Therapeutics Inc.

FSTX | $7.12 0.0% 0 twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-03-14
Market Cap: $ 156,511,263
http://www.f-star.com
 Sec Filling | Patents | 30 employees


(US) F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm’s product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company is headquartered in Cambridge, the United Kingdom.
cancer   antibody  

add to watch list Paper trade email alert is off

nasdaq:MDVL MedAvail Holdings Inc.

MDVL 4 | $1.8 -0.56% 250K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (542.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (187.57% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 2,905,040
https://medavail.com
 Sec Filling | Patents | 15 employees


(US) MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.
optical  

add to watch list Paper trade email alert is off

nasdaq:VRAY ViewRay, Inc.

VRAY | $0.025 -39.9% -61.87% 110M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-98.0% 1y) (0.0% 2d) (0.0% 3d) (-39.9% 7d) (32.05% volume)
Earnings Calendar: 2023-08-01
Market Cap: $ 4,585,051
http://www.viewray.com
 Sec Filling | Patents | 309 employees


(US) ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.
magnetic resonance   radiation therapy   treatment  

add to watch list Paper trade email alert is off

nasdaq:ZSAN Zosano Pharma Corporation

ZSAN | $0.5576 7.23% -5.85% twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-9.9% 3d) (0.0% 7d) (97.18% volume)
Earnings Calendar: 2022-08-10
Market Cap:
http://www.zosanopharma.com
 Sec Filling | Patents | 56 employees


(US) Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.
microneedle system   qtrypta  

add to watch list Paper trade email alert is off

nasdaq:ZYNE Zynerba Pharmaceuticals, Inc.

ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (225.0% 1y) (0.0% 2d) (0.0% 3d) (2.4% 7d) (13.41% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 70,121,260
http://www.zynerba.com
 Sec Filling | Patents | 28 employees


(US) Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.
neuropsychiatric   msa  

add to watch list Paper trade email alert is off

nyse:PKI PerkinElmer, Inc.

PKI | $115.24 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (-1.7% 1m) (-12.5% 1y) (-1.7% 2d) (-8.0% 3d) (0.0% 7d) (-51.16% volume)
Earnings Calendar: 2023-08-01
Market Cap: $ 14,455,821,070
http://www.perkinelmer.com
 Sec Filling | Patents | 13000 employees


(US) PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
food   diagnostics   treatment  

add to watch list Paper trade email alert is off

nyse:RMED Ra Medical Systems, Inc.

RMED | $0.594 0.0% 78K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-59.9% 1y) (0.0% 2d) (10.0% 3d) (0.0% 7d) (-40.66% volume)
Earnings Calendar:
Market Cap: $ 3,188,398
http://www.ramed.com
 Sec Filling | Patents | 79 employees


(US) Ra Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. Its product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the Dermatology and Vascular business segments. The company was founded by Dean Irwin and Melissa Burstein in 2002 and is headquartered in Carlsbad, CA.
cardiovascular   treatment  

add to watch list Paper trade email alert is off

nyse:IVC Invacare Corporation

IVC | $0.6598 -19.67% 0 twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (-1.4% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (-1.4% 7d) (NaN% volume)
Earnings Calendar: 2023-02-15
Market Cap: $ 24,910,310
http://www.invacare.com
 Sec Filling | Patents | 3900 employees


(US) Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.


add to watch list Paper trade email alert is off

nasdaq:ATRS Antares Pharma, Inc.

ATRS | $5.59 0.0% twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (53.54% volume)
Earnings Calendar: 2022-08-04
Market Cap:
http://www.antarespharma.com
 Sec Filling | Patents | 178 employees


(US) Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.
injection   ycombinator  

Drugs
Otrexup (methotrexate)
XYOSTED (testosterone enanthate)

add to watch list Paper trade email alert is off

nasdaq:AGTC Applied Genetic Technologies Corporation

AGTC | $0.3936 1.23% 0.0% twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-80.43% volume)
Earnings Calendar: 2022-11-08
Market Cap:
http://www.agtc.com
 Sec Filling | Patents | 83 employees


(US) Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.
gene therapies   genetic   clinical trials  

add to watch list Paper trade email alert is off

nasdaq:ARAV Aravive, Inc.

ARAV | $0.0401 4.74% 4M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-97.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-85.6% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 2,949,862
http://www.aravive.com
 Sec Filling | Patents | 17 employees


(US) Aravive, Inc. is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX.
cancer   t-cell   ovarian cancer   treatment   ceiling  

add to watch list Paper trade email alert is off

nasdaq:ATNX Athenex, Inc.

ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-84.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (199.02% volume)
Earnings Calendar: 2022-10-27
Market Cap: $ 1,759,498
http://www.athenex.com
 Sec Filling | Patents | 574 employees


(US) Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Global Supply Chain Platform segment provides supply of active pharmaceutical ingredients (APIs) for clinical and commercial efforts. The Commercial Platform segment involves in the sales and marketing of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.
cancer   tirbanibulin   treatment  

add to watch list Paper trade email alert is off

nasdaq:ATHX Athersys, Inc.

ATHX | $0.1018 -40.86% 95M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-89.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (46.93% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 2,290,644
http://www.athersys.com
 Sec Filling | Patents | 83 employees


(US) Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.
cardiovascular   stem cell   urea   t-cell   neurological   ceiling  

add to watch list Paper trade email alert is off

nasdaq:AVEO AVEO Pharmaceuticals, Inc.

AVEO | $15.0 0.0% 0 twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-03-13
Market Cap: $ 521,446,905
http://www.aveooncology.com
 Sec Filling | Patents | 19 employees


(US) AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
urea  

add to watch list Paper trade email alert is off

nasdaq:CNCE Concert Pharmaceuticals, Inc.

CNCE | $8.37 0.36% 0 twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (16.76% volume)
Earnings Calendar: 2023-03-02
Market Cap: $ 520,711,745
http://www.concertpharma.com
 Sec Filling | Patents | 70 employees


(US) Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.
autoimmunity   nervous system   molecule drugs  

add to watch list Paper trade email alert is off

nasdaq:CFRX ContraFect Corporation

CFRX | $0.05 0.0% 910K twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (-97.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (2396.14% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 535,240
http://www.contrafect.com
 Sec Filling | Patents | 24 employees


(US) ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
antibody   monoclonal antibodies   infectious disease   influenza   treatment   bloodstream   injection  

add to watch list Paper trade email alert is off

nasdaq:CTIC CTI BioPharma Corp.

CTIC | $9.09 0.05% 11M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (71.6% 1y) (0.0% 2d) (-0.1% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-08-07
Market Cap: $ 1,198,790,800
http://www.ctibiopharma.com
 Sec Filling | Patents | 25 employees


(US) CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
acquisitions   cancer   treatment  

add to watch list Paper trade email alert is off

nasdaq:CBAY CymaBay Therapeutics Inc.

CBAY | $32.48 0.03% 8.4M twitter stocktwits trandingview |
Health Technology
(0.0% 1d) (0.0% 1m) (214.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-56.22% volume)
Earnings Calendar: 2024-03-14
Market Cap: $ 3,726,247,895
http://www.cymabay.com
 Sec Filling | Patents | 60 employees


(US) CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce gout flares and serum uric acid. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
education   liver   liver disease  

add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance
EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services
NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services
INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |

Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M twitter stocktwits trandingview |
n/a
 | 23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M twitter stocktwits trandingview |
Finance
 | 22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K twitter stocktwits trandingview |
Health Technology
 | 22:30
BCDA P 2750 | $0.377 -1.4% 97K twitter stocktwits trandingview |
Health Technology
 | 22:00
RMCF | $3.67 3.38% 3.27% 11K twitter stocktwits trandingview |
Consumer Non-Durables
 | 20:10
12 months watchlist earnings calendar